Graded Nodal/Activin Signaling Titrates Conversion of Quantitative Phospho-Smad2 Levels into Qualitative Embryonic Stem Cell Fate Decisions

English version České info

Nodal and Activin are morphogens of the TGFbeta superfamily of signaling molecules that direct differential cell fate decisions in a dose- and distance-dependent manner. During early embryonic development the Nodal/Activin pathway is responsible for the specification of mesoderm, endoderm, node, and mesendoderm. In contradiction to this drive towards cellular differentiation, the pathway also plays important roles in the maintenance of self-renewal and pluripotency in embryonic and epiblast stem cells. The molecular basis behind stem cell interpretation of Nodal/Activin signaling gradients and the undertaking of disparate cell fate decisions remains poorly understood. Here, we show that any perturbation of endogenous signaling levels in mouse embryonic stem cells leads to their exit from self-renewal towards divergent differentiation programs. Increasing Nodal signals above basal levels by direct stimulation with Activin promotes differentiation towards the mesendodermal lineages while repression of signaling with the specific Nodal/Activin receptor inhibitor SB431542 induces trophectodermal differentiation. To address how quantitative Nodal/Activin signals are translated qualitatively into distinct cell fates decisions, we performed chromatin immunoprecipitation of phospho-Smad2, the primary downstream transcriptional factor of the Nodal/Activin pathway, followed by massively parallel sequencing, and show that phospho-Smad2 binds to and regulates distinct subsets of target genes in a dose-dependent manner. Crucially, Nodal/Activin signaling directly controls the Oct4 master regulator of pluripotency by graded phospho-Smad2 binding in the promoter region. Hence stem cells interpret and carry out differential Nodal/Activin signaling instructions via a corresponding gradient of Smad2 phosphorylation that selectively titrates self-renewal against alternative differentiation programs by direct regulation of distinct target gene subsets and Oct4 expression.

Vyšlo v časopise: Graded Nodal/Activin Signaling Titrates Conversion of Quantitative Phospho-Smad2 Levels into Qualitative Embryonic Stem Cell Fate Decisions. PLoS Genet 7(6): e32767. doi:10.1371/journal.pgen.1002130
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pgen.1002130

Souhrn

Zdroje

1. AsheHLBriscoeJ 2006 The interpretation of morphogen gradients. Development 133 385 394

2. GurdonJBBourillotPY 2001 Morphogen gradient interpretation. Nature 413 797 803

3. TabataTTakeiY 2004 Morphogens, their identification and regulation. Development 131 703 712

4. GreenJBSmithJC 1990 Graded changes in dose of a Xenopus activin A homologue elicit stepwise transitions in embryonic cell fate. Nature 347 391 394

5. GurdonJBHargerPMitchellALemaireP 1994 Activin signalling and response to a morphogen gradient. Nature 371 487 492

6. ChenYSchierAF 2001 The zebrafish Nodal signal Squint functions as a morphogen. Nature 411 607 610

7. Perea-GomezAVellaFDShawlotWOulad-AbdelghaniMChazaudC 2002 Nodal antagonists in the anterior visceral endoderm prevent the formation of multiple primitive streaks. Dev Cell 3 745 756

8. MavrakisKJAndrewRLLeeKLPetropoulouCDixonJE 2007 Arkadia enhances Nodal/TGF-beta signaling by coupling phospho-Smad2/3 activity and turnover. PLoS Biol 5 e67 doi:10.1371/journal.pbio.0050067

9. VincentSDDunnNRHayashiSNorrisDPRobertsonEJ 2003 Cell fate decisions within the mouse organizer are governed by graded Nodal signals. Genes Dev 17 1646 1662

10. ConlonFLLyonsKMTakaesuNBarthKSKispertA 1994 A primary requirement for nodal in the formation and maintenance of the primitive streak in the mouse. Development 120 1919 1928

11. TremblayKDHoodlessPABikoffEKRobertsonEJ 2000 Formation of the definitive endoderm in mouse is a Smad2-dependent process. Development 127 3079 3090

12. JamesDLevineAJBesserDHemmati-BrivanlouA 2005 TGFbeta/activin/nodal signaling is necessary for the maintenance of pluripotency in human embryonic stem cells. Development 132 1273 1282

13. XiaoLYuanXSharkisSJ 2006 Activin A maintains self-renewal and regulates fibroblast growth factor, Wnt, and bone morphogenic protein pathways in human embryonic stem cells. Stem Cells 24 1476 1486

14. BronsIGSmithersLETrotterMWRugg-GunnPSunB 2007 Derivation of pluripotent epiblast stem cells from mammalian embryos. Nature 448 191 195

15. BeattieGMLopezADBucayNHintonAFirpoMT 2005 Activin A maintains pluripotency of human embryonic stem cells in the absence of feeder layers. Stem Cells 23 489 495

16. WhitmanMRafteryL 2005 TGFbeta signaling at the summit. Development 132 4205 4210

17. ReissmannEJornvallHBlokzijlAAnderssonOChangC 2001 The orphan receptor ALK7 and the Activin receptor ALK4 mediate signaling by Nodal proteins during vertebrate development. Genes Dev 15 2010 2022

18. KelberJAShaniGBookerECValeWWGrayPC 2008 Cripto is a noncompetitive activin antagonist that forms analogous signaling complexes with activin and nodal. J Biol Chem 283 4490 4500

19. KumarANovoselovVCelesteAJWolfmanNMten DijkeP 2001 Nodal signaling uses activin and transforming growth factor-beta receptor-regulated Smads. J Biol Chem 276 656 661

20. MoustakasASouchelnytskyiSHeldinCH 2001 Smad regulation in TGF-beta signal transduction. J Cell Sci 114 4359 4369

21. FunabaMZimmermanCMMathewsLS 2002 Modulation of Smad2-mediated signaling by extracellular signal-regulated kinase. J Biol Chem 277 41361 41368

22. KretzschmarMDoodyJTimokhinaIMassagueJ 1999 A mechanism of repression of TGFbeta/ Smad signaling by oncogenic Ras. Genes Dev 13 804 816

23. WicksSJLuiSAbdel-WahabNMasonRMChantryA 2000 Inactivation of smad-transforming growth factor beta signaling by Ca(2+)-calmodulin-dependent protein kinase II. Mol Cell Biol 20 8103 8111

24. AbdollahSMacias-SilvaMTsukazakiTHayashiHAttisanoL 1997 TbetaRI phosphorylation of Smad2 on Ser465 and Ser467 is required for Smad2-Smad4 complex formation and signaling. J Biol Chem 272 27678 27685

25. SouchelnytskyiSTamakiKEngstromUWernstedtCten DijkeP 1997 Phosphorylation of Ser465 and Ser467 in the C terminus of Smad2 mediates interaction with Smad4 and is required for transforming growth factor-beta signaling. J Biol Chem 272 28107 28115

26. ShiYMassagueJ 2003 Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 113 685 700

27. DennlerSHuetSGauthierJM 1999 A short amino-acid sequence in MH1 domain is responsible for functional differences between Smad2 and Smad3. Oncogene 18 1643 1648

28. DunnNRKoonceCHAndersonDCIslamABikoffEK 2005 Mice exclusively expressing the short isoform of Smad2 develop normally and are viable and fertile. Genes Dev 19 152 163

29. NomuraMLiE 1998 Smad2 role in mesoderm formation, left-right patterning and craniofacial development. Nature 393 786 790

30. ZhuYRichardsonJAParadaLFGraffJM 1998 Smad3 mutant mice develop metastatic colorectal cancer. Cell 94 703 714

31. KoinumaDTsutsumiSKamimuraNTaniguchiHMiyazawaK 2009 Chromatin immunoprecipitation on microarray analysis of Smad2/3 binding sites reveals roles of ETS1 and TFAP2A in transforming growth factor beta signaling. Mol Cell Biol 29 172 186

32. HamadaHMenoCWatanabeDSaijohY 2002 Establishment of vertebrate left-right asymmetry. Nat Rev Genet 3 103 113

33. ChenCShenMM 2004 Two modes by which Lefty proteins inhibit nodal signaling. Curr Biol 14 618 624

34. HanyuAIshidouYEbisawaTShimanukiTImamuraT 2001 The N domain of Smad7 is essential for specific inhibition of transforming growth factor-beta signaling. J Cell Biol 155 1017 1027

35. ShiratoriHSakumaRWatanabeMHashiguchiHMochidaK 2001 Two-step regulation of left-right asymmetric expression of Pitx2: initiation by nodal signaling and maintenance by Nkx2. Mol Cell 7 137 149

36. SaijohYAdachiHMochidaKOhishiSHiraoA 1999 Distinct transcriptional regulatory mechanisms underlie left-right asymmetric expression of lefty-1 and lefty-2. Genes Dev 13 259 269

37. DenissovaNGPouponnotCLongJHeDLiuF 2000 Transforming growth factor beta -inducible independent binding of SMAD to the Smad7 promoter. Proc Natl Acad Sci U S A 97 6397 6402

38. von GersdorffGSusztakKRezvaniFBitzerMLiangD 2000 Smad3 and Smad4 mediate transcriptional activation of the human Smad7 promoter by transforming growth factor beta. J Biol Chem 275 11320 11326

39. HayashiHAbdollahSQiuYCaiJXuYY 1997 The MAD-related protein Smad7 associates with the TGFbeta receptor and functions as an antagonist of TGFbeta signaling. Cell 89 1165 1173

40. InmanGJNicolasFJCallahanJFHarlingJDGasterLM 2002 SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7. Mol Pharmacol 62 65 74

41. Guzman-AyalaMLeeKLMavrakisKJGoggolidouPNorrisDP 2009 Graded Smad2/3 activation is converted directly into levels of target gene expression in embryonic stem cells. PLoS ONE 4 e4268 doi:10.1371/journal.pone.0004268

42. HerrmannBG 1991 Expression pattern of the Brachyury gene in whole-mount TWis/TWis mutant embryos. Development 113 913 917

43. VincentzJWMcWhirterJRMurreCBaldiniAFurutaY 2005 Fgf15 is required for proper morphogenesis of the mouse cardiac outflow tract. Genesis 41 192 201

44. SalgueiroAMFilipeMBeloJA 2006 N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase expression during early mouse embryonic development. Int J Dev Biol 50 705 708

45. Ralston A, Cox BJ, Nishioka N, Sasaki H, Chea E, et al. Gata3 regulates trophoblast development downstream of Tead4 and in parallel to Cdx2. Development 137 395 403

46. HomePRaySDuttaDBronshteynILarsonM 2009 GATA3 is selectively expressed in the trophectoderm of peri-implantation embryo and directly regulates Cdx2 gene expression. J Biol Chem 284 28729 28737

47. ShiDKellemsRE 1998 Transcription factor AP-2gamma regulates murine adenosine deaminase gene expression during placental development. J Biol Chem 273 27331 27338

48. WerlingUSchorleH 2002 Transcription factor gene AP-2 gamma essential for early murine development. Mol Cell Biol 22 3149 3156

49. ConstanciaMAngioliniESandoviciISmithPSmithR 2005 Adaptation of nutrient supply to fetal demand in the mouse involves interaction between the Igf2 gene and placental transporter systems. Proc Natl Acad Sci U S A 102 19219 19224

50. ConstanciaMHembergerMHughesJDeanWFerguson-SmithA 2002 Placental-specific IGF-II is a major modulator of placental and fetal growth. Nature 417 945 948

51. SaijohYAdachiHSakumaRYeoCYYashiroK 2000 Left-right asymmetric expression of lefty2 and nodal is induced by a signaling pathway that includes the transcription factor FAST2. Mol Cell 5 35 47

52. SmolenGASchottBJStewartRADiederichsSMuirB 2007 A Rap GTPase interactor, RADIL, mediates migration of neural crest precursors. Genes Dev 21 2131 2136

53. HartAHHartleyLSourrisKStadlerESLiR 2002 Mixl1 is required for axial mesendoderm morphogenesis and patterning in the murine embryo. Development 129 3597 3608

54. NiederlanderCWalshJJEpiskopouVJonesCM 2001 Arkadia enhances nodal-related signalling to induce mesendoderm. Nature 410 830 834

55. AdachiHSaijohYMochidaKOhishiSHashiguchiH 1999 Determination of left/right asymmetric expression of nodal by a left side-specific enhancer with sequence similarity to a lefty-2 enhancer. Genes Dev 13 1589 1600

56. NorrisDPRobertsonEJ 1999 Asymmetric and node-specific nodal expression patterns are controlled by two distinct cis-acting regulatory elements. Genes Dev 13 1575 1588

57. SunXMeyersENLewandoskiMMartinGR 1999 Targeted disruption of Fgf8 causes failure of cell migration in the gastrulating mouse embryo. Genes Dev 13 1834 1846

58. BoettgerTWittlerLKesselM 1999 FGF8 functions in the specification of the right body side of the chick. Curr Biol 9 277 280

59. NiwaHMiyazakiJSmithAG 2000 Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat Genet 24 372 376

60. NiwaHToyookaYShimosatoDStrumpfDTakahashiK 2005 Interaction between Oct3/4 and Cdx2 determines trophectoderm differentiation. Cell 123 917 929

61. XuRHSampsell-BarronTLGuFRootSPeckRM 2008 NANOG is a direct target of TGFbeta/activin-mediated SMAD signaling in human ESCs. Cell Stem Cell 3 196 206

62. Watanabe Y, Itoh S, Goto T, Ohnishi E, Inamitsu M, et al. TMEPAI, a transmembrane TGF-beta-inducible protein, sequesters Smad proteins from active participation in TGF-beta signaling. Mol Cell 37 123 134

63. StroscheinSLWangWZhouSZhouQLuoK 1999 Negative feedback regulation of TGF-beta signaling by the SnoN oncoprotein. Science 286 771 774

64. PessahMMaraisJPrunierCFerrandNLallemandF 2002 c-Jun associates with the oncoprotein Ski and suppresses Smad2 transcriptional activity. J Biol Chem 277 29094 29100

65. KatkovIIKimMSBajpaiRAltmanYSMercolaM 2006 Cryopreservation by slow cooling with DMSO diminished production of Oct-4 pluripotency marker in human embryonic stem cells. Cryobiology 53 194 205

66. AdlerSPellizzerCPaparellaMHartungTBremerS 2006 The effects of solvents on embryonic stem cell differentiation. Toxicol In Vitro 20 265 271

67. ChuaSWVijayakumarPNissomPMYamCYWongVV 2006 A novel normalization method for effective removal of systematic variation in microarray data. Nucleic Acids Res 34 e38